Clinical Trial Search Results
A Lifetime Partnership with Patients Who Have or May be at Risk of Having Cancer
This study is currently enrolling.
We are asking to study your blood, bone marrow samples, tissues and other body fluids and any parts that make up these tissues, along with your clinical records and survey information. We are building a large database of inform ...
A Multi-center, Randomized, Double-blind, Placebo controlled Phase III Study to Assess the Efficacy, Safety, and Tolerability of PXT3003 in Charcot-Marie-Tooth Type 1A
This study is currently enrolling.
The main purpose of this study is to investigate how effective PXT3003 is when compared to a placebo, on the disease progression and symptoms of CMT1A. The study also aims to assess the safety and tolerability (whether side ef ...
A Phase 1 Dose Escalation With Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMV564 Alone and in Combination with Pembrolizumab in Subjects with Advanced Solid Tumors
This study is currently enrolling.
The purpose of this clinical research study is to learn more about the safety of AMV564, and to learn how AMV564 affects your cancer-specific cells and other blood cells. In addition, the study will look at how long AMV564 can ...
A Phase 2 Study of Blinatumomab (NSC# 765986, IND# 125462) in Combination with Nivolumab (NSC# 748726, IND# 125462), a Checkpoint Inhibitor of PD-1, in B-ALL Patients Aged greater than or equal to 1 and less than 31 Years Old with First Relapse
This study is currently enrolling.
A Phase 2 Trial of MRTX849 in Combination with Pembrolizumab in Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation
This study is currently enrolling.
The main purpose of this study is to evaluate the clinical activity of MRTX849 administered in combination with pembrolizumab in the first-line treatment setting to subjects with Advanced Non-Small Cell Lung Cancer (NSCLC) with ...
A Phase II/III Study of Peri-operative Nivolumab and Ipilimumab in Patients with Locoregional Esophageal and Gastroesophageal Junction Adenocarcinoma
This study is currently enrolling.
This study is being done to answer the following questions: (1) What are the good and bad effects of using usual chemotherapy and radiation plus the immunotherapy, nivolumab, before standard surgery for your condition?; (2) Wha ...
AcQForce - Acqblate Force Sensing Ablation System US IDE for Atrial Flutter
This study is currently enrolling.
The purpose of this study is to demonstrate the safety and efficacy of the Acutus Medical AcQBlate Force Sensing Ablation System when used to treat atrial flutter (AFL). The System is very similar to other devices that FDA has ...
An Open-label, Randomized Phase 3 Study to Evaluate Efficacy and Safety of Pembrolizumab (MK-3475) in Combination with MK-6482 and Lenvatinib (MK-7902), or MK-1308A in Combination with Lenvatinib, versus Pembrolizumab and Lenvatinib, as First-line Treatment in Participants with Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
This study is currently enrolling.
This trial is testing 3 combination therapies in people with a specific type of kidney cancer called advanced clear cell renal cell carcinoma (ccRCC). These 3 therapies are: (1) HIF triplet: pembrolizumab plus MK-6482 (belzutif ...
Antiplatelet Removal and HemocompatIbility Events with the HeartMate 3 Pump
This study is currently enrolling.
The purpose of this research study is to understand if aspirin is needed in patients implanted with the HeartMate 3. Patients with devices like the HeartMate 3 take two blood thinner medicines, specifically warfarin and aspirin ...